FIELD: medicine. SUBSTANCE: method involves administering pharmaceutical composition comprising purine nucleoside or its analog to patients after insult or suffering from central nervous system injuries. EFFECT: enhanced effectiveness of treatment. 17 cl, 8 dwg
Authors
Dates
2003-09-20—Published
1998-02-20—Filed